Literature DB >> 1351811

Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone.

E T Agbenyega1, A C Wareham.   

Abstract

1. The ability of clenbuterol to antagonize the catabolic effect of the glucocorticoid dexamethasone on the skeletal muscles, soleus, gastrocnemius and extensor digitorum longus was studied in mice. 2. Daily injections of 5 mg dexamethasone/kg body weight over 10 days caused a significant (20%) loss of muscle weight and protein content in fast twitch but not in slow twitch muscles. 3. Inclusion of clenbuterol (4 mg/kg) in the diet for the period of dexamethasone treatment partly prevented glucocorticoid-induced muscle atrophy, and increasing the concentration of clenbuterol to 8 mg/kg diet totally prevented glucocorticoid-induced protein loss in all muscles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351811     DOI: 10.1016/0300-9629(92)90026-m

Source DB:  PubMed          Journal:  Comp Biochem Physiol Comp Physiol


  12 in total

1.  Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.

Authors:  R H Morton; E T Agbenyega; P A Hatton; A C Wareham
Journal:  Pflugers Arch       Date:  1995-12       Impact factor: 3.657

Review 2.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

3.  Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity.

Authors:  Sílvia Busquets; Míriam Toledo; Sònia Sirisi; Marcel Orpí; Roberto Serpe; Joana Coutinho; Raquel Martínez; Josep M Argilés; Francisco J López-Soriano
Journal:  Exp Ther Med       Date:  2011-04-28       Impact factor: 2.447

Review 4.  Brain metastases: treatment options to improve outcomes.

Authors:  Phillip Davey
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

Authors:  Sílvia Busquets; Míriam Toledo; Enrica Marmonti; Marcel Orpí; Eva Capdevila; Angelica Betancourt; Francisco J López-Soriano; Josep M Argilés
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

Review 6.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

7.  Muscle ring finger 1 mediates cardiac atrophy in vivo.

Authors:  Monte S Willis; Mauricio Rojas; Luge Li; Craig H Selzman; Ru-Hang Tang; William E Stansfield; Jessica E Rodriguez; David J Glass; Cam Patterson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

8.  Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?

Authors:  Míriam Toledo; Sílvia Busquets; Elisabet Ametller; Francisco J López-Soriano; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-02-24       Impact factor: 12.910

9.  Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.

Authors:  Michael A Pearen; James G Ryall; Gordon S Lynch; George Eo Muscat
Journal:  BMC Genomics       Date:  2009-09-23       Impact factor: 3.969

10.  Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.

Authors:  Daisuke Umeki; Yoshiki Ohnuki; Yasumasa Mototani; Kouichi Shiozawa; Kenji Suita; Takayuki Fujita; Yoshiki Nakamura; Yasutake Saeki; Satoshi Okumura
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.